BioScrip (BIOS)
Create an Alert
15.98
+0.19 +1.20%
NASDAQ
Jun 18, 5:00PM
BATS Real time
Currency in USD
BioScrip Revenue Quarterly YoY Growth:
27.91% for March 31, 2013BioScrip Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 27.91% |
| Dec. 31, 2012 | 14.20% |
| Sept. 30, 2012 | 27.30% |
| June 30, 2012 | 18.49% |
| March 31, 2012 | 18.95% |
| Dec. 31, 2011 | |
| Sept. 30, 2011 | -69.66% |
| June 30, 2011 | -68.07% |
| March 31, 2011 | -60.95% |
| Dec. 31, 2010 | |
| Sept. 30, 2010 | 32.29% |
| June 30, 2010 | 25.33% |
| March 31, 2010 | 2.86% |
| Dec. 31, 2009 | -6.83% |
| Sept. 30, 2009 | -7.22% |
| June 30, 2009 | -5.65% |
| March 31, 2009 | -0.53% |
| Dec. 31, 2008 | 18.56% |
| Sept. 30, 2008 | 20.78% |
| June 30, 2008 | 18.22% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
BIOS Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Abbott Laboratories | 1.78% |
| Daiichi Sankyo | -2.35% |
| Astellas Pharma | -10.74% |
BIOS Revenue Quarterly YoY Growth Rankings
| Overall |
92nd percentile 1238 of 16773 |
| Sector |
87th percentile 176 of 1408 in Healthcare |
| Industry |
90th percentile 13 of 135 in Drug Manufacturers - Major |
BIOS Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -69.66% | Sep 2011 |
| Maximum | 32.29% | Sep 2010 |
| Average | 0.33% |
